Rekombinanter TNF alpha (Nerelimomab Biosimilar) Antikörper
Kurzübersicht für Rekombinanter TNF alpha (Nerelimomab Biosimilar) Antikörper (ABIN7597850)
Target
Antikörpertyp
Reaktivität
Wirt
Klonalität
Güteklasse
-
-
Expressionssystem
- Mammalian cells
-
Verwendungszweck
- Research Grade Nerelimomab Biosimilar Antibody
-
Spezifität
- TNF, Tumor necrosis factor ligand superfamily member 2, N-terminal fragment, ICD2, NTF, TNF-a, TNF-alpha, Tumor necrosis factor, TNFSF2, TNFA, Cachectin, ICD1
-
Aufreinigung
- Protein A or G purified from cell culture supernatant.
-
Reinheit
- >95 % by SDS-PAGE.
-
Isotyp
- IgG1
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Haltbarkeit
- 12 months
-
-
- TNF alpha (Nerelimomab Biosimilar)
-
Andere Bezeichnung
- Nerelimomab Biosimilar
-
Substanzklasse
- Biosimilar
-
Hintergrund
- TNF, Tumor necrosis factor ligand superfamily member 2, N-terminal fragment, ICD2, NTF, TNF-a, TNF-alpha, Tumor necrosis factor, TNFSF2, TNFA, Cachectin, ICD1
-
UniProt
- P01375
-
CAS-Nummer
- 162774-06-3
Target
-